Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study
Hepatology2013Vol. 58(1), pp. 264–272
Citations Over TimeTop 10% of 2013 papers
Lina Zhang, Tian‐Yan Shi, Xuhua Shi, Li Wang, Yunjiao Yang, Bin Liu, Lixia Gao, Zongwen Shuai, Fang Kong, Hua Chen, Wei Han, Shaomei Han, Yunyun Fei, Quancai Cui, Qian Wang, Min Shen, Dong Xu, Wenjie Zheng, Yongzhe Li, Wen Zhang, Xuan Zhang, Fengchun Zhang
Abstract
For the previously published criteria, biochemical responses at the sixth month can be used in place of those evaluated after 1 year of UDCA therapy. Our findings justify a more rapid identification of patients who need new therapeutic approaches.
Related Papers
- → Management of Primary Biliary Cirrhosis and Autoimmune Cholangitis(1998)12 cited
- → Effects of ursodeoxycholic acid (UDCA) on survival in patients with primary biliary cirrhosis (PBC)(1995)3 cited
- → Mo1004 Predictors and Durability of Biochemical Response to Ursodeoxycholic Acid (UDCA) in Patients With Primary Biliary Cirrhosis (PBC): A Long-Term Follow-Up Study(2015)1 cited
- → Tu1003 Primary Non-Response to Ursodeoxycholic Acid Is Associated With Lower Vitamin D Levels in Patients With Primary Biliary Cirrhosis(2013)
- → The effect of ursodeoxycholic acid (UDCA) on anti-mitochondrial antibody (AMA) titre in primary biliary cirrhosis (PBC)(1995)